Novo Nordisk, however, does have savings cards that can help reduce the self-pay cost
Semaglutide was the most cost-effective treatment compared to exenatide, dulaglutide, liraglutide, or no treatment in short-term analyses (approximately one and a half years) that assessed quality-adjusted life years and incremental cost-effectiveness ratios [135,136,137,138,139,140,141,142,143,144]
While initially billed as a treatment for diabetes, many of the drugs that utilize GLP-1 agonists are now sold as a dedicated anti-obesity palliative option
Providers should submit laboratory results including fasting glucose, HbA1c, and lipid panel alongside the authorization request